Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
NCT ID: NCT01203085
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2010-04-30
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
NCT02979145
Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions
NCT05661071
Muscle Activity With the Use of Ankle Foot Orthoses in Cerebral Palsy
NCT00462085
Effects of Electromechanical Gait Trainer in Patients With Cerebral Palsy
NCT01564433
Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)
NCT01125709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric patients
All patients 21 years of age and under who are enrolled in the 6601 study and have undergone the pediatric scale tests.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children (\< 21 years of age)
* Known or probable inherited neuropathies classified as CMT1, CMT2, or CMT4
Exclusion Criteria
* Entirely normal conduction velocities of upper and lower limbs as this suggests that the subject may not have a neuropathy.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Muscular Dystrophy Association
OTHER
University of Rochester
OTHER
Children's Hospital of Philadelphia
OTHER
University College London Hospitals
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
Sydney Children's Hospitals Network
OTHER
Nemours Children's Clinic
OTHER
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Shy
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael E Shy, MD
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Palo Alto, California, United States
University of Connecticut/Connecticut Children's Medical Center
Hartford, Connecticut, United States
Nemours Children's Clinic
Orlando, Florida, United States
University of Iowa
Iowa City, Iowa, United States
University of Michigan
Ann Arbor, Michigan, United States
University of Rochester
Rochester, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Seattle Children's Hospital
Seattle, Washington, United States
Children's Hospital of Westmead
Sydney, New South Wales, Australia
The Hospital for Sick Children
Toronto, Ontario, Canada
C. Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, , Italy
National Hospital of Neurology and Neurosurgery
London, England, United Kingdom
Dubowitz Neuromuscular Centre
London, UK, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Inherited Neuropathy Consortium Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INC-6603
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.